advertisement
Harris A 35
Showing records 1 to 25 | Display all abstracts from Harris A70086 Differences in Ocular Blood Flow Between People of African and European Descent With Healthy Eyes
Kaskan B
Journal of Glaucoma 2016; 25: 709-715
69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Harris A
Journal of Glaucoma 2016; 25: e826-e833
70329 Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research
Koustenis A
British Journal of Ophthalmology 2017; 101: 16-20
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Miller Ellis E
British Journal of Ophthalmology 2017; 101: 796-800
70087 Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent
Siesky B
Journal of Glaucoma 2016; 25: 750-757
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Berlin MS
British Journal of Ophthalmology 2017; 101: 796-800
70329 Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research
Harris A
British Journal of Ophthalmology 2017; 101: 16-20
70087 Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent
Harris A
Journal of Glaucoma 2016; 25: 750-757
70086 Differences in Ocular Blood Flow Between People of African and European Descent With Healthy Eyes
Ramezani K
Journal of Glaucoma 2016; 25: 709-715
69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Ward CL; Rowe-Rendleman CL
Journal of Glaucoma 2016; 25: e826-e833
70087 Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent
Carr J
Journal of Glaucoma 2016; 25: 750-757
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Ward CL
British Journal of Ophthalmology 2017; 101: 796-800
70086 Differences in Ocular Blood Flow Between People of African and European Descent With Healthy Eyes
Harris A
Journal of Glaucoma 2016; 25: 709-715
70329 Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research
Gross J
British Journal of Ophthalmology 2017; 101: 16-20
70086 Differences in Ocular Blood Flow Between People of African and European Descent With Healthy Eyes
Siesky B
Journal of Glaucoma 2016; 25: 709-715
70087 Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent
Verticchio Vercellin A
Journal of Glaucoma 2016; 25: 750-757
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Sharpe JA
British Journal of Ophthalmology 2017; 101: 796-800
70329 Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research
Januleviciene I
British Journal of Ophthalmology 2017; 101: 16-20
69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Ouchi T
Journal of Glaucoma 2016; 25: e826-e833
70329 Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research
Shah A
British Journal of Ophthalmology 2017; 101: 16-20
70087 Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent
Hussain RM
Journal of Glaucoma 2016; 25: 750-757
69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Wood A
Journal of Glaucoma 2016; 25: e826-e833
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Jamil A
British Journal of Ophthalmology 2017; 101: 796-800
70086 Differences in Ocular Blood Flow Between People of African and European Descent With Healthy Eyes
Olinde C
Journal of Glaucoma 2016; 25: 709-715
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Harris A
British Journal of Ophthalmology 2017; 101: 796-800
